Precedex Injection, Solution
Product Images NDC 0409-7838

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Precedex (NDC 0409-7838). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Precedex 01)

Chemical structure of Dexmedetomidine Hydrochloride, the active ingredient in Precedex injection solution, depicted with labeled atoms and bonds including a hydrochloride component.*

FDA Label Image

Logo (Precedex 02)

FDA Label Image

Principal Display Panel (50 mL Bottle Label)

Precedex 200 mcg/50 mL (4 mcg/mL) dexmedetomidine hydrochloride injection label. This single-dose intravenous solution bottle contains dexmedetomidine HCl in 0.9% sodium chloride. The label includes usage instructions, storage conditions, and manufacturer Hospira, Inc. The bottle size is 50 mL with a concentration of 4 mcg/mL.*

FDA Label Image

Principal Display Panel (50 mL Bottle Tray)

Label for Precedex (dexmedetomidine hydrochloride) injection, 4 mcg/mL concentration (200 mcg/50 mL), intravenous solution. The label specifies a single-dose bottle containing 20 units of 50 mL each. Labeler is Hospira, Inc. Instructions indicate discarding unused portions.*

FDA Label Image

Principal Display Panel (100 mL Bottle Label)

Precedex 400 mcg/100 mL (4 mcg/mL) injection solution label for dexmedetomidine hydrochloride in 0.9% sodium chloride. The label indicates a single-dose 100 mL bottle, for intravenous use, containing preservative-free solution. It notes storage instructions, product pH range, and that it is distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (100 mL Bottle Tray)

Label for Precedex 400 mcg/100 mL (4 mcg/mL) intravenous injection, dexmedetomidine hydrochloride in 0.9% sodium chloride solution. The package contains 10 units of 100 mL single-dose bottles. Manufactured by Hospira, Inc., the label includes usage instructions and storage conditions.*

FDA Label Image

Principal Display Panel (20 mL Vial Label)

Label for Precedex (Dexmedetomidine HCl) Injection, a single-dose vial containing 80 mcg per 20 mL (4 mcg/mL) in 0.9% Sodium Chloride. The label indicates intravenous use, preservative-free formulation, and storage instructions. Distributed by Hospira, Inc., Lake Forest, IL. Includes a barcode and lot/expiration information areas.*

FDA Label Image

Principal Display Panel (20 mL Vial Carton)

The image shows the packaging label for Precedex 80 mcg/20 mL (4 mcg/mL) injection, solution for intravenous use. It contains Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride. The package includes 10 single-dose vials of 20 mL each. The labeler is Hospira, Inc., and the product is made in Finland. Storage and usage instructions are provided, emphasizing preservative-free composition and specific storage temperatures.*

FDA Label Image

Principal Display Panel (2 mL Vial Label)

Precedex Dexmedetomidine HCl Injection label showing 200 mcg/2 mL (100 mcg/mL) strength. The 2 mL intravenous injection solution is distributed by Hospira, Inc. The label includes NDC 0409-1638-32 and instructions indicating the product must be diluted before use.*

FDA Label Image

Principal Display Panel (2 mL Vial Tray)

Packaging label for Precedex (Dexmedetomidine HCl) Injection, solution for intravenous use. The label indicates a 2 mL single-dose vial with a concentration of 100 mcg/mL (200 mcg/2 mL). It is preservative-free and must be diluted before use. The product is distributed by Hospira, Inc., and the label includes NDC 0409-1638-02 and barcoding details.*

FDA Label Image

Principal Display Panel (250 mL Bottle Label)

Label for Precedex Dexmedetomidine HCl 1,000 mcg/250 mL (4 mcg/mL) Injection, Solution in 0.9% Sodium Chloride for intravenous use. The bottle is single-dose with discard unused portion instructions. The label includes dosage concentration, storage conditions, barcode, and is distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (250 mL Bottle Carton)

Packaging label for Precedex 1,000 mcg/250 mL (4 mcg/mL) injection, solution containing Dexmedetomidine HCl in 0.9% Sodium Chloride for intravenous use. The label states it is a single-dose bottle with 1 unit per 250 mL. Distributed by Hospira, Inc., with storage instructions and preservative-free designation. Includes barcode and GTIN information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.